
21 October 2015
4 questions with Lani Teddy, Melanoma Institute Australia Research Project Manager who was a driving force in the team to create the new information packs Your Guide to Early Melanoma.
What is “Your Guide to Early Melanoma” and how will it help patients?
People’s need for information following a melanoma diagnosis varies a great deal. When people have questions, whether about melanoma generally or specifically about their diagnosis, treatment, or follow-up care, they often don’t know where to turn or what information to trust. “Your Guide to Early Melanoma” is a dedicated information resource for people diagnosed with Stage I or II melanoma.
How long did the project take and who was involved?
A number of health professionals, a GP, surgeons, dermatologists and clinical nurse consultants provided content and feedback. We were fortunate that a group of ten volunteers (patients, carers and family members) also thoroughly critiqued an early version of this resource. People who have been through the experience of a melanoma diagnosis have thought about the types of questions they had when first diagnosed, what information they have gone looking for since and provided suggestions not only on the content, but also more broadly on how the resource should look and ideas about how this should be distributed. And of course we are very grateful to have the support of Neutrogena, without which this work may not have happened. The resource took about 8 months to produce from first draft to printing.
It is believed that patient support is a missing resource. How are the support packs addressing a support and information need?
There is a lot of variability in the types of information and support that people are after. Some people want to know about support groups, some people want to see pictures of melanoma, others want to understand the way melanoma is staged and have questions about nutrition, sunscreen, Vitamin D, prognosis, genetics, what happens at follow-up…the list goes on. Some people want to know everything up front, others only want to know what is relevant right now, and may have questions later on. While the information and support packs won’t provide all the answers, they are a good starting point and provide a lot of references if people want more in-depth information. It is also something that can be shared with family and friends if they have questions about melanoma.
What is psychosocial care and why is it so important for patients?
Psychosocial and supportive care is about recognising and responding to the numerous ways that people are affected by a cancer diagnosis. The provision of information that is easy to access and easy to understand is one part of the much broader scope for supporting patients and families through diagnosis and treatment. Patients (and their families) require a holistic approach to treatment, which therefore includes addressing psychological, social, dietary and physical issues as well as excellent medical care.

A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.

Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.

It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.

Prof Richard Scolyer named Outstanding Cancer Researcher of the Year
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.

Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.

MIA researchers feature on prestigious Highly Cited Researchers 2020 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.

Game On Mole is back this summer!
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.

RCPA recognition for Professor Richard Scolyer.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.

Professor Georgina Long hands on baton of SMR Presidency
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.

City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!

Top melanoma experts at MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.

Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.

Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.

Research reveals long-term benefit of adjuvant therapy for Stage III melanoma

New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.

New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.

Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.

Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.

Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.

Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.